292 related articles for article (PubMed ID: 29016807)
1. A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma.
Rahme GJ; Luikart BW; Cheng C; Israel MA
Neuro Oncol; 2018 Feb; 20(3):332-342. PubMed ID: 29016807
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway.
Yang Y; Dodbele S; Park T; Glass R; Bhat K; Sulman EP; Zhang Y; Abounader R
J Neurooncol; 2019 Oct; 145(1):23-34. PubMed ID: 31482267
[TBL] [Abstract][Full Text] [Related]
3. PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-Mediated Survival of Proneural Glioma Cells.
Rahme GJ; Zhang Z; Young AL; Cheng C; Bivona EJ; Fiering SN; Hitoshi Y; Israel MA
Cancer Res; 2016 May; 76(10):2964-76. PubMed ID: 26951930
[TBL] [Abstract][Full Text] [Related]
4. The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin.
Peng G; Wang Y; Ge P; Bailey C; Zhang P; Zhang D; Meng Z; Qi C; Chen Q; Chen J; Niu J; Zheng P; Liu Y; Liu Y
J Exp Clin Cancer Res; 2021 Sep; 40(1):278. PubMed ID: 34470658
[TBL] [Abstract][Full Text] [Related]
5. Pleiotrophin enhances PDGFB-induced gliomagenesis through increased proliferation of neural progenitor cells.
Zhang L; Laaniste L; Jiang Y; Alafuzoff I; Uhrbom L; Dimberg A
Oncotarget; 2016 Dec; 7(49):80382-80390. PubMed ID: 27806344
[TBL] [Abstract][Full Text] [Related]
6. Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis.
Vitucci M; Karpinich NO; Bash RE; Werneke AM; Schmid RS; White KK; McNeill RS; Huff B; Wang S; Van Dyke T; Miller CR
Neuro Oncol; 2013 Oct; 15(10):1317-29. PubMed ID: 23814263
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma.
Clara CA; Marie SK; de Almeida JR; Wakamatsu A; Oba-Shinjo SM; Uno M; Neville M; Rosemberg S
Neuropathology; 2014 Aug; 34(4):343-52. PubMed ID: 24612214
[TBL] [Abstract][Full Text] [Related]
8. Murine cell line model of proneural glioma for evaluation of anti-tumor therapies.
Sonabend AM; Yun J; Lei L; Leung R; Soderquist C; Crisman C; Gill BJ; Carminucci A; Sisti J; Castelli M; Sims PA; Bruce JN; Canoll P
J Neurooncol; 2013 May; 112(3):375-82. PubMed ID: 23504257
[TBL] [Abstract][Full Text] [Related]
9. miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis.
Silber J; Jacobsen A; Ozawa T; Harinath G; Pedraza A; Sander C; Holland EC; Huse JT
PLoS One; 2012; 7(3):e33844. PubMed ID: 22479456
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor in glioblastoma-driver or biomarker?
Westermark B
Ups J Med Sci; 2014 Nov; 119(4):298-305. PubMed ID: 25342206
[TBL] [Abstract][Full Text] [Related]
11. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
[TBL] [Abstract][Full Text] [Related]
12. A cell-autonomous positive-signaling circuit associated with the PDGF-NO-ID4-regulatory axis in glioblastoma cells.
Eun K; Jeon HM; Kim SO; Choi SH; Lee SY; Jin X; Kim SC; Kim H
Biochem Biophys Res Commun; 2017 Apr; 486(2):564-570. PubMed ID: 28327358
[TBL] [Abstract][Full Text] [Related]
13. In vitro modeling of glioblastoma initiation using PDGF-AA and p53-null neural progenitors.
Bohm AK; DePetro J; Binding CE; Gerber A; Chahley N; Berger ND; Ware M; Thomas K; Senapathi U; Bukhari S; Chen C; Chahley E; Grisdale C; Lawn S; Yu Y; Wong R; Shen Y; Omairi H; Mirzaei R; Alshatti N; Pedersen H; Yong W; Weiss S; Chan J; Cimino PJ; Kelly J; Jones S; Holland E; Blough M; Cairncross G
Neuro Oncol; 2020 Aug; 22(8):1150-1161. PubMed ID: 32296841
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
[TBL] [Abstract][Full Text] [Related]
15. Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model.
Hesselager G; Uhrbom L; Westermark B; Nistér M
Cancer Res; 2003 Aug; 63(15):4305-9. PubMed ID: 12907595
[TBL] [Abstract][Full Text] [Related]
16. PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals.
Cenciarelli C; Marei HE; Felsani A; Casalbore P; Sica G; Puglisi MA; Cameron AJ; Olivi A; Mangiola A
Oncotarget; 2016 Aug; 7(33):53047-53063. PubMed ID: 27344175
[TBL] [Abstract][Full Text] [Related]
17. SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.
Moncayo G; Grzmil M; Smirnova T; Zmarz P; Huber RM; Hynx D; Kohler H; Wang Y; Hotz HR; Hynes NE; Keller G; Frank S; Merlo A; Hemmings BA
Neuro Oncol; 2018 Apr; 20(5):621-631. PubMed ID: 29401256
[TBL] [Abstract][Full Text] [Related]
18. Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis.
Ortiz B; Fabius AW; Wu WH; Pedraza A; Brennan CW; Schultz N; Pitter KL; Bromberg JF; Huse JT; Holland EC; Chan TA
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8149-54. PubMed ID: 24843164
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model.
Andreou T; Williams J; Brownlie RJ; Salmond RJ; Watson E; Shaw G; Melcher A; Wurdak H; Short SC; Lorger M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33707311
[TBL] [Abstract][Full Text] [Related]
20. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
